Eosinophilic pneumonia differential diagnosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 40: Line 40:
{| class="wikitable"
{| class="wikitable"
!
!
!
!Clinical Picture
!
!Laboratory diagnosis
!
!Imaging
!Treatment
|-
|-
|Acute eosinophilic pneumonia
|Acute eosinophilic pneumonia
|Onset <1 month
|
|
|
|
Line 50: Line 52:
|-
|-
|Chronic eosinophilic pneumonia
|Chronic eosinophilic pneumonia
|Onset >2–4 week
|
|
|
|
Line 55: Line 58:
|-
|-
|Transpulmonary passage of helminth larvae
|Transpulmonary passage of helminth larvae
|
|
|
|
|
Line 60: Line 64:
|-
|-
|Allergic bronchopulmonary aspergillosis
|Allergic bronchopulmonary aspergillosis
|
|
|
|
|
Line 66: Line 71:
|Eosinophilic granulomatosis with polyangitis
|Eosinophilic granulomatosis with polyangitis
|
|
|
* Peripheral blood eosinophilia: Between 5 and
20,000/mm
* BAL eosinophilia greater than 25% and usually greater than 40%
* Increase in serum IgE and C-reactive protein
* ANCAs are found in only 40% of patients
|
|
|
|

Revision as of 02:28, 12 February 2018

Pneumonia Main Page

Eosinophilic pneumonia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Eosinophilic pneumonia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Eosinophilic pneumonia differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Eosinophilic pneumonia differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Eosinophilic pneumonia differential diagnosis

CDC onEosinophilic pneumonia differential diagnosis

Eosinophilic pneumonia differential diagnosis in the news

Blogs on Eosinophilic pneumonia differential diagnosis

Directions to Hospitals Treating Eosinophilic pneumonia

Risk calculators and risk factors for Eosinophilic pneumonia differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Acute eosinophilic pneumonia may be differentiated from other causes of pulmonary eosinophilia

Acute eosinophilic pneumonia (AEP)

  • The cause of acute eosinophilic pneumonia is unknown.
  • Some investigators have suggested that AEP is an acute hypersensitivity reaction to an unidentified inhaled antigen in an otherwise healthy individual [1].

Transpulmonary passage of helminth larvae (Löffler syndrome)

  • Three types of helminths, Ascaris (A. lumbricoidesA. suum), hookworms (Ancylostoma duodenaleNecator americanus), and Strongyloides stercoralis, have larvae that reach the lungs, penetrate into alveoli, and ascend the airways then reach the gastrointestinal tract. [10]
  • Ascaris is the most common cause of Löffler syndrome worldwide. [11]

Tropical pulmonary eosinophilia

  • Tropical pulmonary eosinophilia is immune response to the bloodborne microfilarial stages of the lymphatic filariae and Wuchereria bancrofti. [16-18].
  • The typical symptoms are cough, breathlessness, wheezing, fatigue, and fever. Pulmonary function tests may show a mixed restrictive and obstructive abnormality with a reduction in diffusion capacity. [18]

Eosinophilic granulomatosis with polyangitis

  • Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) is a vasculitic disorder often characterized by sinusitis, asthma, and prominent peripheral blood eosinophilia. [49]
  • It is the sole form of vasculitis that is associated with both eosinophilia and frequent lung involvement. In addition to the lungs, the skin and the cardiovascular, gastrointestinal, renal, and neurologic systems may also be involved.

Allergic bronchopulmonary aspergillosis

  • Allergic bronchopulmonary aspergillosis (ABPA) is a complex hypersensitivity reaction that occurs when airways become colonized by Aspergillus. [51]
  • Repeated episodes of bronchial obstruction, inflammation, and mucoid impaction can lead to bronchiectasis, fibrosis, and respiratory compromise.
  • Immunologic responses elicited by Aspergillus fumigatus are responsible for this syndrome.

Drugs and toxins

Drug reaction with eosinophilia and systemic symptoms (DRESS) is a drug-induced hypersensitivity reaction that includes skin eruption, eosinophilia, atypical lymphocytosis, lymphadenopathy, and kidney involvement. Drugs causing DRESS are:

  • Nonsteroidal anti-inflammatory drugs (NSAIDs) [26]
  • anticonvulsants
  • antidepressants
  • angiotensin converting enzyme inhibitors
  • beta blockers
  • hydrochlorothiazide
  • sulfa-containing compounds [27]

Differential Diagnosis

Clinical Picture Laboratory diagnosis Imaging Treatment
Acute eosinophilic pneumonia Onset <1 month
Chronic eosinophilic pneumonia Onset >2–4 week
Transpulmonary passage of helminth larvae
Allergic bronchopulmonary aspergillosis
Eosinophilic granulomatosis with polyangitis
  • Peripheral blood eosinophilia: Between 5 and

20,000/mm

  • BAL eosinophilia greater than 25% and usually greater than 40%
  • Increase in serum IgE and C-reactive protein
  • ANCAs are found in only 40% of patients

References

Template:WH Template:WS